T8	Exp 181 185	that
T9	Exp 103 121	The nuclear factor
T10	Exp 196 210	the regulation
T11	Exp 214 233	the immune response
T12	Exp 337 342	which
T13	Exp 359 378	the phosphorylation
T14	Exp 461 463	we
T15	Exp 476 480	that
T16	Exp 481 508	the simultaneous activation
T17	Exp 537 574	the TCR-initiated signal transduction
T18	Exp 627 653	the synergistic activation
T19	Exp 657 694	the IkappaBalpha kinase (IKK) complex
T20	Exp 754 756	We
T21	Exp 774 778	that
T22	Exp 779 794	the IKK complex
T23	Exp 889 906	the co-activation
T24	Exp 984 990	either
T25	Exp 1004 1018	the activation
T26	Exp 1022 1037	the IKK complex
T27	Exp 931 952	Each second messenger
T28	Exp 1157 1161	that
T29	Exp 1178 1188	the target
T30	Exp 1237 1241	that
T31	Exp 1249 1267	the TCR/CD3 signal
T32	Exp 1331 1355	the effective activation
T33	Exp 1359 1374	the IKK complex
T34	Exp 1214 1227	These results
R3	Coref Anaphora:T8 Antecedent:T35
R4	Coref Anaphora:T12 Antecedent:T36
T1	Protein 398 410	IkappaBalpha
T2	Protein 723 742	IkappaBalpha kinase
T3	Protein 744 752	p90(rsk)
T4	Protein 804 812	p90(rsk)
T5	Protein 864 876	IkappaBalpha
T6	Protein 1042 1054	IkappaBalpha
T7	Protein 1167 1174	IKKbeta
T35	Exp 147 180	a ubiquitous transcription factor
T36	Exp 326 335	NF-kappaB
